Aquaculture North America

Products
Phibro acquires vaccines manufacturer

Phibro Animal Health Corp has acquired the assets of KoVax Ltd, an Israel-based developer and manufacturer of vaccines for the global aquaculture market.


March 6, 2019
By Liza Mayer

The acquisition strengthens Phibro’s position in fish vaccine innovation and expands its portfolio of aquaculture products.

KoVax’s research and development team has joined Phibro’s biological R&D team, and will focus on developing a pipeline of innovative vaccines for the aquaculture market.

Phibro’s first commercial aquaculture vaccine is KoVax’s “KV3” vaccine, which helps prevent Koi Herpes Virus, a highly contagious disease that can cause significant mortality in common carp farms.


Print this page

Related



Leave a Reply

Your email address will not be published. Required fields are marked *

*